Condition
Parasitologically Confirmed; Malarial
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Artemetherlumefantrine Combination
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Phase 4 (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Artemetherlumefantrine Combination1
Active Sponsors
- Australian Agency for International Development1
- Papua New Guinea Institute of Medical Research1
- National Department of Health, Papua New Guinea1
Top Investigators
Papua New Guinea Institute of Medical Research
Walter and Eliza Hall Institute of Medical Research
Papua New Guinea Institute of Medical Research